Search clinical trials for: Clopidogrel 75

Total 1107 results

HK inno.N Corporation

Completed

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Healthy

Korea, Republic of
First Affiliated Hospital of Harbin Medical University

Unknown

Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

Platelet Reactivity

China
University Hospital, Bordeaux
Ministry for Health and Solidarity, France

Completed

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous (CLOPUS)

Systemic Lupus Erythematous

France
Labopharm Inc.

Completed

A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers

Healthy

United Kingdom
Janssen Korea, Ltd., Korea

Completed

A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition

Healthy

Korea, Republic of
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer (TRAPEZE)

Pain

France
Yonsei University

Recruiting

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Atrial Fibrillation

Korea, Republic of
Ping-Yen Liu

Unknown

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients (APROVE-CKD)

Chronic Kidney Disease | Acute Coronary Syndrome | End-Stage Renal Disease

Taiwan
Novo Nordisk A/S

Terminated

Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding

Healthy | Haemostasis

United States
Creighton University

Withdrawn

Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents

Coronary Artery Disease

United States
Sanofi

Completed

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Arteriosclerosis

France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United States, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finlan... and more
Sanofi

Completed

Mixed Antagonist of Serotonin for Claudication Optimal Therapy (MASCOT)

Intermittent Claudication

United States, Canada, Russian Federation, Ukraine, Germany, Sweden, Belgium, Czech Republic, Mexico
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Gilead Sciences

Completed

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa (AIR-CF1)

Cystic Fibrosis

United States, Canada, Australia, New Zealand
Gilead Sciences

Completed

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa (AIR-CF4)

Cystic Fibrosis | Pseudomonas Aeruginosa | Lung Infection

United States, Australia, Canada
Shanghai Institute of Hypertension

Recruiting

Home Blood Pressure Intervention in the Community Trial

Home Blood Pressure

China
The Cleveland Clinic
Novartis Pharmaceuticals

Completed

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Osteoporosis

United States
Washington University School of Medicine
Novartis Pharmaceuticals

Terminated

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Uterine Cervical Neoplasms

United States
Roswell Park Cancer Institute

Terminated

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Multiple Myeloma and Plasma Cell Neoplasm

United States
Federal State Budgetary Institution, V. A. Almazov...

Recruiting

Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia

Intracranial Aneurysm

Russian Federation
Seung-Jung Park
CardioVascular Research Foundation, Korea

Active, not recruiting

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS LATE)

Coronary Disease | Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
The First Affiliated Hospital with Nanjing Medical...

Unknown

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Acute Coronary Syndrome (ACS)

China
Taipei City Hospital

Completed

Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)

Stable Angina

Taiwan
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients (PANDDA)

Diabetes

Canada
Samsung Medical Center

Unknown

Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE) (SMART-DATE)

Acute Coronary Syndrome

Korea, Republic of
Centre de Recherche de l'Institut Universitaire...

Recruiting

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure (ANDES)

Stroke | Thrombosis | Bleeding | Left Atrial Appendage Closure | TIA

Canada
Shenyang Northern Hospital

Not yet recruiting

Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI

Rivaroxaban
Vastra Gotaland Region
Uppsala University; Gothia Forum - Center for Clinical Trial

Recruiting

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome (TACSI)

Acute Coronary Syndrome

Denmark, Sweden, Norway, Finland, Iceland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Major Depressive Disorder

Japan
Yonsei University

Unknown

Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke Patients

Stroke

Korea, Republic of
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital; American Society...

Completed

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

Multiple Myeloma

United States
Jules Desmeules

Terminated

Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (IMPACT/R)

Hiv

Switzerland
Ain Shams Maternity Hospital

Unknown

Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI

Female , Infertility

Egypt
AstraZeneca

Withdrawn

Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients (PAD)

Intermittent Claudication | Peripheral Artery Disease | Vascular Disease | Arterial Occlusion Disease | Ankle Brachial Index (0.9 or Less)
Marco Valgimigli

Completed

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY)

Coronary Artery Disease

Italy
Hospital Álvaro Cunqueiro

Unknown

Registry of Acute Coronary Syndrome From University Hospital of Vigo (CardioCHUVI)

Acute Coronary Syndrome

Spain
Imam Abdulrahman Bin Faisal University
King Fahad Armed Forces Hospital; Dammam Central Hospital

Unknown

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

Myocardial Infarction | Infarction | Ischemia | Coronary Artery Disease | Cardiovascular Disease | Embolism | Thrombosis | Chest Pain | Angina Pectoris | Heart Disease | Vascular Disease

Saudi Arabia
Sanofi
Bristol-Myers Squibb

Completed

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction (CLARITY-TIMI28)

Acute Coronary Syndromes

Russian Federation, Belgium, Brazil, France, Germany, Hungary, Italy, Mexico, Netherlands, South Africa, Spain, Sweden, United States, Argentina, Australia, Ireland, Israel, Turkey, Austria, Poland, Canada, Portugal, Puerto Rico, United...
National Taiwan University Hospital
Haemonetics Corporation

Unknown

Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

30 Healthy People

Taiwan
Catholic University of the Sacred Heart

Unknown

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

Cardiovascular Disease | Polyvascular Disease

Italy
Karolinska University Hospital
Philips Medical Systems

Completed

Image Quality and Radiation Dose in Angiography

Arteriovenous Malformations | Aneurysm | Stenosis | Dural Arteriovenous Malformations

Sweden
Seoul National University Hospital

Completed

A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir (CES1)

Healthy

Korea, Republic of
Pharmahungary Group
Hoffmann-La Roche

Completed

Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation

Influenza

Hungary
Novartis Pharmaceuticals

Withdrawn

The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA

Prosthetic Fixation After Cementless Total Hip Arthroplasty

China
Germans Trias i Pujol Hospital

Completed

Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort

HIV Infections

Spain
Gyeongsang National University Hospital
Korean Society of Interventional Cardiology

Completed

PTRG-DES Consortium (PTRG)

Coronary Artery Disease | Stent Thrombosis | Clopidogrel, Poor Metabolism of | Platelet Dysfunction

Korea, Republic of
Laval University
Bristol-Myers Squibb; Sanofi

Completed

Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects (CANOA)

Migraine

Canada
University of Zagreb
Clinical Hospital Centre Zagreb; Ministry of Science, Education and Sport,...

Completed

Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity

Acute Coronary Syndrome

Croatia
University College Dublin
Royal College of Surgeons, Ireland; National Maternity Hospital, Ireland; Perinatal...

Completed

Trial of Early Screening Test for Pre-eclampsia and Growth Restriction (TEST)

Placenta Diseases | Pre-Eclampsia | Fetal Growth Retardation | Eclampsia Preeclampsia | Foetal Growth Restriction

Ireland
Janssen Research & Development, LLC

Terminated

Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)

Healthy

United States

Search clinical trials for: Clopidogrel 75

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations